Psychiatric Times • Aug 7 2023 According to the National Community Pharmacists Association, 97% of independent pharmacy owners reported shortages of Adderall in early 2023. As these shortages continue, here’s how you can best support your patients with ADHD. Class […]
By Richard Gawel | Perspective from Jeffrey A. Lieberman, MD | Perspective from Benjamin Ungar, MD | Fact checked by Kristen Dowd Atopic dermatitis was associated with increased odds of schizophrenia and schizoaffective disorder, according to a study published […]
By ERIN SCHUMAKER and KATHERINE ELLEN FOLEY08/12/2023 07:00 AM EDT There’s a new cause in Washington that’s uniting Republicans, Democrats and Biden health officials: psychedelics as a cure for America’s mental health crisis. Long derided as counterculture party drugs, psychedelics […]
Psychiatric Times • April 17 2023 By Jeffrey A. Lieberman, M.D. As the NCAA “March Madness” basketball tournament reached its emotional peak, thousands of high school students and parents experienced a March madness of their own as they awaited college […]
New York Daily News • Mar 01 2023 By Dr. Jeffrey A. Lieberman, Steven Leifman and Dr. E. Fuller Torrey Mayor Adams’ plan to get homeless individuals with serious mental illnesses off the streets and into treatment echoes past initiatives […]
Literary Hub • Feb 21 2023 “The Miracle Cure.” A Brief History of Lobotomies: Dr. Jeffrey A. Lieberman on Early Psychosurgery—and Its Impact on the Kennedys and Tennessee Williams Excerpted from Malady of the Mind by Jeffrey Lieberman. Copyright (c) […]
Washington Post • June 1 2021 By Liz Clarke with commentary from Jeffrey A. Lieberman, M.D. Although she has withdrawn from the French Open, tennis star Naomi Osaka this week scored a victory that athletes and advocates say will have […]
The New England Journal of Medicine • April 15 2021In The Doors of Perception, Aldous Huxley described his trial of mescaline as “the most extraordinary and significant experience available to human beings this side of the Beatific Vision.” His exegesis was […]
New York Daily News • June 19, 2019 By Carl J. McCall, Jeffrey A. Lieberman , Randy P. Auerbach As the spring semester comes to a close on college campuses and students depart for internships and jobs, and otherwise while […]
Forbes • Sept 14 2016 By Jeffrey Lieberman Departing from the massive complex of buildings that house the Food and Drug Administration after a meeting with the new FDA Commissioner, Robert Califf, I felt something that I rarely have felt […]
Throughout his forty year career Jeffrey Lieberman, MD has focused on research and clinical care of patients with serious mental illness.
